Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if ESLA is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
3 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 4
15 filers reported a long position in ESLA for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | $4.1M | 4M | -3% |
| VANGUARD CAPITAL MANAGEMENT LLC | $433.5K | 416.9K | +9% |
| GEODE CAPITAL MANAGEMENT, LLC | $147K | 141.3K | -10.3% |
| VANGUARD FIDUCIARY TRUST CO | $67.5K | 64.9K | Unchanged |
| BlackRock, Inc. | $54.1K | 52K | +30.4% |
| STATE STREET CORP | $45K | 43.3K | Unchanged |
| RENAISSANCE TECHNOLOGIES LLC | $40.7K | 39.1K | -37.7% |
| NORTHERN TRUST CORP | $36.3K | 34.9K | +77.6% |
| US BANCORP \DE\ | $20.8K | 20K | +18.3% |
| Tower Research Capital LLC (TRC) | $3.4K | 3.3K | -31.9% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.